SUBSCRIBE
SUBSCRIBE

Metacrine, Inc.

NEWS
Business
Elevian Launches to Join Numerous Companies Focused on Longevity and Aging
In another example of companies focused on aging-related diseases, Elevian launched with $5.5 million in seed funding. Elevian’s founders came out of Stanford and then Harvard, focused on regenerative effects of “young blood.”
September 7, 2018
 · 
3 min read
 · 
Mark Terry
Load More
AWARDS
  • NextGen Class of 2016
JOBS
IN THE PRESS
Business
Metacrine Reports Third-Quarter 2021 Results
November 11, 2021
 · 
6 min read
Drug Development
Metacrine Reports Topline Results for MET409 Phase 2a Combination Trial In Patients with Type 2 Diabetes and NASH
November 2, 2021
 · 
5 min read
Drug Development
Metacrine Reports Interim Results for MET642 Phase 2a Trial in Patients with NASH and Announces a Strategic Re-Prioritization of Its Clinical Development Programs
October 21, 2021
 · 
7 min read
Drug Development
Metacrine Achieves Full Enrollment for MET642 Phase 2a Trial in Patients With Nash
September 9, 2021
 · 
4 min read
Biotech Beach
Metacrine to Host Virtual R&D Day for Analysts and Investors on September 15, 2021
September 8, 2021
 · 
3 min read
Biotech Beach
Metacrine to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 7, 2021
 · 
1 min read
Business
Metacrine Updates MET642 Clinical Development Milestone and Reports Second-Quarter 2021 Results
August 12, 2021
 · 
8 min read
Biotech Beach
Metacrine to Present at 2021 Canaccord Genuity Growth Conference
August 9, 2021
 · 
1 min read
Biotech Beach
Metacrine to Present New Preclinical Data in Inflammatory Bowel Disease (IBD) at European Crohn’s and Colitis Organisation (ECCO) 2021 Virtual Congress
July 6, 2021
 · 
3 min read
Biotech Beach
Metacrine and Its Partners to Present Data at the EASL International Liver Congress™ 2021
June 17, 2021
 · 
2 min read
Load More